Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1COUMADIN

02 1DICLOFENAC SODIUM

03 1GABAPENTIN

04 1OXYBUTYNIN CHLORIDE

05 1OXYCODONE HYDROCHLORIDE

06 1PRAVACHOL

07 1RIFATER

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

ISONIAZID; PYRAZINAMIDE; RIFAMPIN

Drug : RIFATER

Dosage Form : TABLET; ORAL

Application Number : 50705

Country : US

Patented : No

Sanofi Company Banner

02

arrow
Aus. Peptide Conference
Not Confirmed

03

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

DICLOFENAC SODIUM

Drug : DICLOFENAC SODIUM

Dosage Form : TABLET, DELAYED RELEASE; ORAL

Application Number : 74514

Country : US

Patented : No

blank

04

arrow
Aus. Peptide Conference
Not Confirmed

05

arrow
Aus. Peptide Conference
Not Confirmed

06

arrow
Aus. Peptide Conference
Not Confirmed

07

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

OXYCODONE HYDROCHLORIDE

Drug : OXYCODONE HYDROCHLORIDE

Dosage Form : TABLET; ORAL

Application Number : 77290

Country : US

Patented : No

blank